Metabolic Tumor Volume by ¹⁸F-FDG PET/CT Can Predict the Clinical Outcome of Primary Malignant Spine/Spinal Tumors

Figure 3

Kaplan-Meier estimate of progression-free survival by MTV and by TLG. Data were categorized according to the optimal cut-off value for MTV (a) and TLG (b) defined with ROC curve analysis.

(a)

(b)